Patents by Inventor Stuart G. Field

Stuart G. Field has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof
    Publication number: 20230071234
    Abstract: Methods, compositions, and kits for determining whether a subject has a liver condition, including hepatic steatosis, hepatic inflammation, hepatocellular ballooning, and/or hepatic fibrosis, are provided. In various embodiments, the subject's liver condition includes non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: February 9, 2021
    Publication date: March 9, 2023
    Applicant: SomaLogic Operating Co., Inc.
    Inventors: Leigh Alexander, Rachel Ostroff, Stuart G. Field
  • Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
    Patent number: 10359435
    Abstract: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: July 23, 2019
    Assignee: SomaLogic, Inc.
    Inventors: Malti Nikrad, Stuart G. Field, Stephen Alaric Williams
  • NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
    Publication number: 20180259537
    Abstract: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
    Type: Application
    Filed: March 2, 2018
    Publication date: September 13, 2018
    Applicant: SOMALOGIC, INC.
    Inventors: Malti NIKRAD, Stuart G. FIELD, Stephen Alaric WILLIAMS
  • Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
    Patent number: 9945875
    Abstract: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: April 17, 2018
    Assignee: SomaLogic, Inc.
    Inventors: Malti Nikrad, Stuart G. Field, Stephen Alaric Williams
  • NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
    Publication number: 20170227550
    Abstract: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
    Type: Application
    Filed: February 16, 2017
    Publication date: August 10, 2017
    Applicant: SOMALOGIC, INC.
    Inventors: Malti NIKRAD, Stuart G. FIELD, Stephen Alaric WILLIAMS
  • Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
    Patent number: 9612248
    Abstract: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: April 4, 2017
    Assignee: SomaLogic, Inc.
    Inventors: Malti Nikrad, Stuart G. Field, Stephen Alaric Williams
  • Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
    Patent number: 9423403
    Abstract: Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided. Methods, compositions, and kits for predicting whether lung function is likely to decline in a subject with COPD or at risk for developing COPD are also provided.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: August 23, 2016
    Assignee: SomaLogic, Inc.
    Inventors: Malti P. Nikrad, Stuart G. Field, Stephen Alaric Williams, Alex A. E. Stewart, Rachel M. Ostroff, Rosalynn Dianne Gill
  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BIOMARKERS AND USES THEREOF
    Publication number: 20150377903
    Abstract: Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided. Methods, compositions, and kits for predicting whether lung function is likely to decline in a subject with COPD or at risk for developing COPD are also provided.
    Type: Application
    Filed: June 30, 2015
    Publication date: December 31, 2015
    Inventors: Malti P. Nikrad, Stuart G. Field, Stephen Alaric Williams, Alex A.E. Stewart, Rachel M. Ostroff, Rosalynn Dianne Gill
  • Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
    Patent number: 9103837
    Abstract: Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided. Methods, compositions, and kits for predicting whether lung function is likely to decline in a subject with COPD or at risk for developing COPD are also provided.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: August 11, 2015
    Assignee: SOMALOGIC, INC.
    Inventors: Malti P. Nikrad, Stuart G. Field, Stephen Alaric Williams, Alex A. E. Stewart, Rachel M. Ostroff, Rosalynn Dianne Gill
  • NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
    Publication number: 20140303018
    Abstract: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
    Type: Application
    Filed: March 10, 2014
    Publication date: October 9, 2014
    Applicant: SomaLogic, Inc.
    Inventors: Malti Nikrad, Stuart G. Field, Stephen Alaric Williams
  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BIOMARKERS AND USES THEREOF
    Publication number: 20140135302
    Abstract: Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided. Methods, compositions, and kits for predicting whether lung function is likely to decline in a subject with COPD or at risk for developing COPD are also provided.
    Type: Application
    Filed: November 7, 2013
    Publication date: May 15, 2014
    Applicant: SOMALOGIC, INC.
    Inventors: Malti P. Nikrad, Stuart G. Field, Stephen Alaric Williams, Alex A.E. Stewart, Rachel M. Ostroff, Rosalynn Dianne Gill